Genmab — November 2020
-
We are pleased to share our financial
calendar for 2021. For details, visit https://ir.genmab.com/financial-cale -
the new kid on the block with a new Ph2 trial -A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma https://www.clinicaltrials.gov/ct2/show/NCT04634552?term=NCT04634552&draw=2&rank=1
-
-
@StockBull, ja, spændende om det er herfra vi skal opad på retracement. Holder nu krudtet tørt indtil videre.
-
Pas nu på du ikke bare venter på Godot..;-)
-
Blood - A Novel Next-Generation FVIII Mimetic, Mim8, Has a Favourable Safety Profile. Results from a 26-Week Safety Study in Cynomolgus Monkeys https://ash.confex.com/ash/2020/webprogram/Paper137006.html
-
-
Det er bare et gæt Klarussen.
-
Lige nu søger markedsdeltagerne bare til noget som de tror/mener er bedre end det de har. Mange af dem har pharma. Det forlader de måske helt eller delvist i en periode, men vender så tilbage igen.
-
Genmab
@Genmab
·
1 t
#ICYMI – @WHO
recently launched a global strategy to eliminate #cervicalcancer, it outlines three key steps: vaccination, screening and treatment. Learn more about the commitment by 194 countries to eliminate cervical cancer.https://www.who.int/news/item/17-11-2020-a-cervical-cancer-free-future-first-ever-global-commitment-to-eliminate-a-cancer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind